FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Holthe David   2. Issuer Name and Ticker or Trading Symbol SOLTA MEDICAL INC [SLTM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O SOLTA MEDICAL, 25881 INDUSTRIAL BLVD. 3. Date of Earliest Transaction (Month/Day/Year) 02/26/2013 (Street) HAYWARD, CA 94545 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/26/2013   A   61,719 (1) (2) A (3) 61,719 D   Common Stock 02/26/2013   A   5,435,993 (2) (4) A (3) 5,435,993 I By Inlign CP III, LLC (5) Common Stock 02/26/2013   A   34,782 (6) A $ 0 96,501 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Holthe David C/O SOLTA MEDICAL 25881 INDUSTRIAL BLVD. HAYWARD, CA 94545	X

Signatures

/s/ John F. Glenn, attorney in fact		02/28/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Received in exchange for membership interest units (the "Units") of Sound Surgical Technologies LLC ("Target") owned by the Reporting Person in connection with the merger of Target into Issuer (the "Merger"). Includes 3,630 shares which are currently being held in escrow and are subject to forfeiture during the 12-month period following the Merger to satisfy claims arising from Target's breach of any of its representations and warranties in the Merger Agreement (as defined below).
(2)	The Merger Agreement further provides that the former members of Target, including Mr. Holthe and Inlign CP III, LLC ("Inlign"), will receive additional shares of Issuer common stock if Target's revenue between January 1, 2013 and December 31, 2013 exceeds $23,100,000 (the "Earn-Out Right"). Mr. Holthe and Inlign's right to receive additional shares pursuant to the Earn-Out Right became fixed and irrevocable on February 26, 2013, the effective date of the Merger.
(3)	Details regarding the consideration received by Issuer for these shares, including the value of such consideration, are provided for in the Agreement and Plan of Merger entered into as of January 29, 2013 by and among Issuer, Target and other parties thereto (the "Merger Agreement"). The Merger Agreement placed a value on the Issuer's common stock of $2.62, which was the volume-weighted average of the closing sales prices for Issuer's common stock on the NASDAQ Stock Market for a specified period prior to the date of the Merger Agreement.
(4)	Received in exchange for Units of Target held by Inlign in connection with the Merger. Includes 319,709 shares which are currently being held in escrow and are subject to forfeiture during the 12-month period following the Merger to satisfy claims arising from Target's breach of any of its representations and warranties in the Merger Agreement.
(5)	Mr. Holthe is a managing director of Inlign. As such, Mr. Holthe may be deemed to share voting and dispositive power with regard to the shares held directly by Inlign. Mr. Holthe disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report will not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
(6)	Deemed acquired pursuant to a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one (1) share of Issuer's common stock. The restricted stock units vest in three annual installments as follows: February 26, 2014, February 26, 2015 and February 26, 2016. Vested shares of the Issuer's common stock will be delivered to the Reporting Person on each such date, provided the Reporting Person continues to provide services to the Issuer as of each such dates.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.